Official Guidance from IDFPR
(Adobe PDF File)

New Guidance to CRNAs from IDFPR

There are several changes that will go into effect on January 1, 2018. In terms of the Nurse Practice Act
and the Controlled Substances Act, CRNAs are not considered any differently than the rest of
APRNs. The CEU requirement for APRNs is increasing from 50 hours to 80 hours. Part of the 80 hours
must now include 10 hours in opioid prescribing or substance abuse education. However, the new CEU
requirement of 80 hours will not be required for the 2018 renewal. The Nurse Practice Act provides the
following regarding CEUs:

The 80 hours of continuing education required under this
Section shall be completed as follows:
(1) A minimum of 50 hours of the continuing education
shall be obtained in continuing education programs as
determined by rule that shall include no less than 20
hours of pharmacotherapeutics, including 10 hours of
opioid prescribing or substance abuse education.
Continuing education programs may be conducted or endorsed
by educational institutions, hospitals, specialist
associations, facilities, or other organizations approved
to offer continuing education under this Act or rules and
shall be in the advanced practice registered nurse's
specialty.
(2) A maximum of 30 hours of credit may be obtained
by presentations in the advanced practice registered
nurse's clinical specialty, evidence-based practice, or
quality improvement projects, publications, research
projects, or preceptor hours as determined by rule.
The rules adopted regarding continuing education shall be
consistent to the extent possible with requirements of
relevant national certifying bodies or State or national
professional associations.


The Controlled Substance Act has not changed the requirements for getting a CS license nor have the
CEUs required to maintain a mid‐level Schedule II CS license. The CS Act provides the following:

(B) the advanced practice nurse has been
delegated authority by a collaborating physician licensed to practice medicine in all
its branches or collaborating podiatric physician to prescribe or dispense Schedule II
controlled substances through a written delegation of authority and under the following
conditions: …
(vi) the advanced practice nurse must provide
evidence of satisfactory completion of at least 45 graduate contact hours
in pharmacology for any new license issued with Schedule II authority after
the effective date of this amendatory Act of the 97th General Assembly; and
(vii) the advanced practice nurse must
annually complete 5 hours of continuing education in pharmacology;


Another change to the CS Act is that any prescriber who hold a CS license must register with the
PMP. This new requirement was a separate amendment and can be found here, but I’ve included the
relevant section below.

(c-5) Effective January 1, 2018,
each prescriber
possessing an Illinois controlled
substances license shall
register with the Prescription
Monitoring Program. Each
prescriber or his or her designee
shall also document an
attempt to access patient
information in the Prescription
Monitoring Program to assess
patient access to controlled
substances when providing an
initial prescription for Schedule
II narcotics such as opioids,
except for prescriptions for
oncology treatment or palliative
care, or a 7-day or less
supply provided by a hospital
emergency department when
treating an acute, traumatic
medical condition. This attempt to
access shall be documented in the
patient's medical record. The
hospital shall facilitate the
designation of a prescriber's
designee for the purpose of
accessing the Prescription
Monitoring Program for services
provided at the hospital.